Market Research Logo

Transdermal Drug Delivery System Market by Type (Patches and Semisolid formulations), Applications (Pain Management, Central Nervous System Disorders, Hormonal Applications, Cardiovascular Diseases), End User, and Region - Global Forecast to 2023

Transdermal Drug Delivery System Market by Type (Patches and Semisolid formulations), Applications (Pain Management, Central Nervous System Disorders, Hormonal Applications, Cardiovascular Diseases), End User, and Region - Global Forecast to 2023

The transdermal drug delivery systems market is projected to grow at a CAGR of 4.5% during the forecast period.
The transdermal drug delivery systems market is expected to reach 7.1 billion by 2023 from an estimated USD 5.7 billion in 2018, at a CAGR of 4.5% during the forecast period. Market growth is largely driven by the global increase in the prevalence of chronic diseases. In addition, technological advancements in transdermal drug delivery systems are expected to support market growth in the coming years. However, drug failures and recalls of transdermal drug delivery systems are expected to restrain market growth to a certain extent.

By application, the pain management segment is expected to grow at the highest rate during the forecast period.
On the basis of application, the transdermal drug delivery systems market is segmented into five broad categories—pain management, central nervous system disorders, hormonal applications, cardiovascular diseases, and other applications (smoking cessation, motion sickness, and overactive bladder treatment). The pain management segment is expected to grow at the highest CAGR during the forecast period owing to the high burden of chronic pain worldwide and the growing availability of transdermal products for pain management.

The transdermal patches segment is expected to dominate the market in 2018.
On the basis of type, the transdermal drug delivery systems market is segmented into transdermal patches and transdermal semisolids. In 2018, the transdermal patches segment is expected to account for a dominant share of the transdermal drug delivery systems market. This drug delivery system offers several advantages, such as reduced dosing frequency, improved bioavailability, reduced adverse events, and drug input termination at any point by the removal of the patch. Also, the use of patches results in increased patient compliance due to their non-invasive nature and painless application. These factors are expected to drive market growth.

The North American transdermal drug delivery systems market is expected to grow at the highest CAGR during the forecast period.
North America, comprising the US and Canada, offers high-growth opportunities for players in the transdermal drug delivery systems market. This segment is slated to register the highest CAGR during the forecast period. Some of the factors driving market growth in the North American region are rising prevalence of targeted diseases (such as chronic pain, central nervous system disorders, and cardiovascular diseases) in the region, the increasing use of contraceptives, and the increasing number of research activities related to transdermal drug delivery systems.

Break of primary participants was as mentioned below:
By Company Type - Tier 1-55%, Tier 2-25% and Tier 3-20%
By Designation - C-level-43%, Director Level-32%, Others-25%
By Region - North America-38%, Europe-29%, Asia Pacific-23%, RoW-10%

The key players in the transdermal drug delivery systems market are Hisamitsu Pharmaceutical (Japan), Mylan (US), UCB (Belgium), Novartis (Switzerland), GlaxoSmithKline (UK), Boehringer Ingelheim (Germany), Johnson & Johnson (US), Endo International (Ireland), and Purdue Pharma (US).

Research Coverage:
The report analyzes the transdermal drug delivery systems market and aims at estimating the market size and future growth potential of this market based on various segments such as applications, type, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies.

This report provides insights into the following pointers:
Market Penetration: Comprehensive information on the services offered by the top players in the transdermal drug delivery systems market. The report analyzes the market based on applications, type, end user, and region
Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the transdermal drug delivery systems market
Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various transdermal drug delivery systems solutions across regions
Market Diversification: Exhaustive information about solutions and services, untapped regions, recent developments, and investments in the transdermal drug delivery systems market
Competitive Assessment: In-depth assessment of market shares, strategies, distribution networks, and manufacturing capabilities of the leading players in the market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZE ESTIMATION
      • MARKET DATA VALIDATION AND TRIANGULATION
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET OVERVIEW
    • TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2018
    • TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2018
    • TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET: GEOGRAPHIC SNAPSHOT
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
  • TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE
    • INTRODUCTION
      • Table COMPARISON BETWEEN TRANSDERMAL PATCHES AND TRANSDERMAL SEMISOLID FORMULATIONS
      • Table TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
    • TRANSDERMAL PATCHES
      • DRUG-IN-ADHESIVE PATCHES
      • MATRIX PATCHES
      • RESERVOIR MEMBRANE PATCHES
      • MICRONEEDLE PATCHES
        • Table TRANSDERMAL PATCHES MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table TRANSDERMAL PATCHES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
    • TRANSDERMAL SEMISOLIDS
      • GELS
      • OINTMENTS
      • SPRAYS
        • Table TRANSDERMAL SEMISOLIDS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION
    • INTRODUCTION
      • Table TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
    • PAIN MANAGEMENT
      • PAIN MANAGEMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET
        • Table TRANSDERMAL DRUG DELIVERY SYSTEMS AVAILABLE FOR PAIN MANAGEMENT
        • Table TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET FOR PAIN MANAGEMENT, BY COUNTRY, 2016-2023 (USD MILLION)
    • HORMONAL APPLICATIONS
      • Table TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET FOR HORMONAL APPLICATIONS, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET FOR HORMONAL APPLICATIONS, BY TYPE, 2016-2023 (USD MILLION)
      • TESTOSTERONE REPLACEMENT THERAPY
        • Table TRANSDERMAL DRUG DELIVERY SYSTEMS AVAILABLE FOR TESTOSTERONE REPLACEMENT THERAPY
      • TRANSDERMAL ESTROGEN THERAPY
        • Table TRANSDERMAL DRUG DELIVERY SYSTEMS AVAILABLE FOR TRANSDERMAL ESTROGEN THERAPY
    • CENTRAL NERVOUS SYSTEM DISORDERS
      • INCREASING INCIDENCE OF PARKINSON'S AND ALZHEIMER'S DISEASE TO DRIVE THE MARKET FOR CENTRAL NERVOUS SYSTEM DISORDERS
        • Table TRANSDERMAL DRUG DELIVERY SYSTEMS AVAILABLE FOR CENTRAL NERVOUS SYSTEM DISORDERS
        • Table TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET FOR CENTRAL NERVOUS SYSTEM DISORDERS, BY COUNTRY, 2016-2023 (USD MILLION)
    • CARDIOVASCULAR DISEASES
      • AVAILABILITY OF ALTERNATIVE AND ADVANCED DRUG DELIVERY OPTIONS TO LIMIT MARKET GROWTH
        • Table TRANSDERMAL DRUG DELIVERY SYSTEMS AVAILABLE FOR CARDIOVASCULAR DISEASES
        • Table TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2016-2023 (USD MILLION)
    • OTHER APPLICATIONS
      • INCREASING DEMAND FOR ADVANCED TRANSDERMAL MICRONEEDLE PATCHES FOR DIABETES MANAGEMENT-A KEY MARKET DRIVER
        • Table TRANSDERMAL DRUG DELIVERY SYSTEMS AVAILABLE FOR OTHER APPLICATIONS
        • Table TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY END USER
    • INTRODUCTION
      • Table TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
    • HOME CARE SETTINGS
      • Table TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2016-2023 (USD MILLION)
    • HOSPITALS & CLINICS
      • Table TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY REGION
    • INTRODUCTION
      • Table TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY REGION, 2016-2023 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
      • Table NORTH AMERICA: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
      • US
        • Table US: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
        • Table US: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table US: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
      • CANADA
        • Table CANADA: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
        • Table CANADA: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table CANADA: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
    • EUROPE
      • Table DEVELOPMENTS IN THE FIELD OF TDDS IN EUROPE, 2015-2018
      • Table EUROPE: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table EUROPE: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
      • Table EUROPE: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
      • Table EUROPE: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
      • GERMANY
        • Table GERMANY: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
        • Table GERMANY: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table GERMANY: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
      • UK
        • Table UK: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
        • Table UK: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table UK: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
      • FRANCE
        • Table FRANCE: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
        • Table FRANCE: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table FRANCE: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
      • ROE
        • Table ROE: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
        • Table ROE: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table ROE: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
    • ASIA PACIFIC
      • Table ASIA PACIFIC: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
      • Table ASIA PACIFIC: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
      • JAPAN
        • Table JAPAN: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
        • Table JAPAN: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table JAPAN: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
      • CHINA
        • Table CHINA: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
        • Table CHINA: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table CHINA: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
      • INDIA
        • Table INDIA: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
        • Table INDIA: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table INDIA: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
      • ROPAC
        • Table ROAPAC: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
        • Table ROAPAC: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
        • Table ROAPAC: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
    • ROW
      • Table ROW: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
      • Table ROW: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, 2016-2023 (USD MILLION)
      • Table ROW: TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET SHARE ANALYSIS
    • MARKET SHARE ANALYSIS, BY APPLICATION
      • PAIN MANAGEMENT
      • HORMONAL APPLICATIONS
      • CENTRAL NERVOUS SYSTEM DISORDERS
      • CARDIOVASCULAR DISEASES
    • COMPETITIVE SCENARIO
      • PRODUCT LAUNCHES AND APPROVALS
        • Table PRODUCT LAUNCHES AND APPROVALS
      • EXPANSIONS
        • Table EXPANSIONS
      • AGREEMENTS AND COLLABORATIONS
        • Table AGREEMENTS AND COLLABORATIONS
      • ACQUISITIONS
  • COMPANY PROFILES
    • HISAMITSU PHARMACEUTICAL CO., INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • MYLAN N.V.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • UCB S.A.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • NOVARTIS AG
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • GLAXOSMITHKLINE PLC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • JOHNSON & JOHNSON (J&J)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ENDO INTERNATIONAL, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • PURDUE PHARMA L.P.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • LAVIPHARM
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • LEAD CHEMICALS CO., INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • LUYE PHARMA GROUP
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report